Clinical trial

Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC)

NCT06793813

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-01-23

PhasePHASE2

Study timeline

Study start (actual)2024-01-23Date precision: day

Registry last updated2025-01-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Stage IVB Lung Cancerunresolved

Non-Squamousunresolved

Interventions

cadonilimab，bevacizumab，docetaxelDRUG

Sponsors & collaborators

Cancer Institute and Hospital, Chinese Academy of Medical Scienceslead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06793813 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.